Table 2.
Disease | Contrast application | Advantages and scoring methods | Comments |
---|---|---|---|
Infective endocarditis and cardiac device infection | ++ |
-Visualization of abscesses -Visualization of thrombi/vegetation on valves/probes -Visualization of septic embolism as infarcts in terminal vessels (e.g., spleen, kidney, brain) -Detailed examination of valves (potentially important in surgical procedures) |
Some imaging centers do not deem the administration of contrast medium to be mandatory. |
Cardiac sarcoidosis | ± | Superior morphological allocation of the PET signal (e.g. myocardial vs. lung uptake; organ involvement) | Contrast agent generally not required if perfusion study (PET and SPECT) is available |
Large vessel vasculitis | ++ |
Visualization of the vessels to exclude relevant stenosis and score wall thickness: 0 = no mural thickening 1 = slight mural thickening 2 = mural thickening 3 = long and strong circumferential mural thickening OR as measurement: >2–3 mm |
In the presence of a recent angiographic scan (CT/MRT), a low-dose CT is sufficient. |
Atherosclerosis | +++ |
Visualization and quantification of calcium, vascular stenosis and plaque composition -Agatston score in mainly applied for calcium burden and risk assessment in coronary artery disease -Vascular stenosis is evaluated on CTA and categorized as non-obstructive or obstructive |
CTA is clinically recommended and aids in the interpretation of the PET scans particularly in the coronary arteries |
Vascular graft infection | +++ |
-Visualization of peri-graft gas and fluid. -Aneurysm expansion/pseudo-aneurysm formation -Detailed examination of vascular graft |
The sensitivity and specificity of CT is moderate and variable |
Cardiac amyloidosis | – | Assessment of thickness of the left ventricular myocardium | Only patients with a clinical suspicion receive this specific examination (septum thickness usually already available). |
-no contribution, ±some contribution, ++good contribution, +++excellent contribution